Languages SpokenEnglish Common ConditionsBased on the training and education, Dr. Michelle Ma, MD may treat patients with the following conditions. Please always check with Dr. Michelle Ma, MD directly about which exact conditions he treats. - Resting Bitch Face
- Hair Loss & Thinning Hair
- Stretched Ears
- Spider Veins
- Unwanted Tattoos
- Sun Damage & Sunburn
- Aging Skin
- Jowls
- Keratosis Pilaris
- Puffy Eyes (Eye Bags)
- Thin Lips
- Overweight & Obesity
- Psoriasis
- Cold Sores
- Cellulite
- Ingrown Hair
- Varicose Veins
- Itchy Skin
- Double Chin
- Chapped Lips
Prescribed MedicationsValacyclovir Doxycycline Hyclate Tretinoin Prednisone Metronidazole Dupixent Syringe (Generic Name: dupilumab) Levocetirizine Dihydrochloride Calcipotriene Ciclopirox (Generic Name: ciclopirox olamine) Mometasone Furoate Research PublicationsApproximately 55% of Dermatologists in Boston, MA have available research publications Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. Duane Moogk, Ines Pires da Silva, Michelle W Ma, Erica B Friedman, Eleazar Vega-Saenz de Miera, Farbod Darvishian, Patrick Scanlon, Arianne Perez-Garcia, Anna C Pavlick, Nina Bhardwaj, Paul J Christos, Iman Osman, Michelle Krogsgaard Journal of translational medicine 2014-12-10 Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis. Meng Qian, Michelle W Ma, Nathaniel H Fleming, Daniel J Lackaye, Eva Hernando, Iman Osman, Yongzhao Shao Melanoma research 2013-12 Melanoma risk loci as determinants of melanoma recurrence and survival. Justin Rendleman, Shulian Shang, Christine Dominianni, Jerry F Shields, Patrick Scanlon, Christina Adaniel, Alexis Desrichard, Michelle Ma, Richard Shapiro, Russell Berman, Anna Pavlick, David Polsky, Yongzhao Shao, Iman Osman, Tomas Kirchhoff Journal of translational medicine 2013-11-04 Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis. Christopher S Hale, Meng Qian, Michelle W Ma, Patrick Scanlon, Russell S Berman, Richard L Shapiro, Anna C Pavlick, Yongzhao Shao, David Polsky, Iman Osman, Farbod Darvishian The American journal of surgical pathology 2013-06 Serum microRNAs as biomarkers for recurrence in melanoma. Erica B Friedman, Shulian Shang, Eleazar Vega-Saenz de Miera, Jacob Ulrik Fog, Maria Wrang Teilum, Michelle W Ma, Russell S Berman, Richard L Shapiro, Anna C Pavlick, Eva Hernando, Adam Baker, Yongzhao Shao, Iman Osman Journal of translational medicine 2012-08-02 Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site. Michelle W Ma, Meng Qian, Daniel J Lackaye, Russell S Berman, Richard L Shapiro, Anna C Pavlick, John G Golfinos, Erik C Parker, Farbod Darvishian, Eva Hernando, Yongzhao Shao, Iman Osman Neuro-oncology 2012-05-03 Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Michelle W Ma, Ratna C Medicherla, Meng Qian, Eleazar Vega-Saenz de Miera, Erica B Friedman, Russell S Berman, Richard L Shapiro, Anna C Pavlick, Patrick A Ott, Nina Bhardwaj, Yongzhao Shao, Iman Osman, Farbod Darvishian Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012-03-16 Single versus multiple primary melanomas: old questions and new answers. Charlotte Hwa, Leah S Price, Ilana Belitskaya-Levy, Michelle W Ma, Richard L Shapiro, Russell S Berman, Hideko Kamino, Farbod Darvishian, Iman Osman, Jennifer A Stein Cancer 2012-01-13 A high proliferative index of recurrent melanoma is associated with worse survival. Ting J Tu, Michelle W Ma, Stefano Monni, Amy E Rose, Herman Yee, Farbod Darvishian, David Polsky, Russell S Berman, Richard L Shapiro, Anna C Pavlick, Madhu Mazumdar, Iman Osman Oncology 2011-06-24 Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities. Lindsay G Wich, Michelle W Ma, Leah S Price, Stanislav Sidash, Russell S Berman, Anna C Pavlick, George Miller, Umut Sarpel, Judith D Goldberg, Iman Osman Journal of community health 2011-06 Payments From Medical Companies(These can include payments from pharmaceutical companies, medical device companies, and other companies.) Dr. Michelle Ma, MD has received over $2,309 in payments from medical companies (92% less than the average Dermatologist in Boston, MA) - Over $2,309 in payments for Food and Beverage (71% more than the average Dermatologist in Boston, MA)
Novartis Pharmaceuticals Corporation - $12.42 payment for Food and Beverage on 12/12/2024 Novartis Pharmaceuticals Corporation - $23.07 payment for Food and Beverage on 12/11/2024 Novartis Pharmaceuticals Corporation - $16.72 payment for Food and Beverage on 12/06/2024 Novartis Pharmaceuticals Corporation - $22.01 payment for Food and Beverage on 10/30/2024 Novartis Pharmaceuticals Corporation - $22.20 payment for Food and Beverage on 10/24/2024 Novartis Pharmaceuticals Corporation - $22.72 payment for Food and Beverage on 10/09/2024 Novartis Pharmaceuticals Corporation - $29.68 payment for Food and Beverage on 10/01/2024 Novartis Pharmaceuticals Corporation - $23.06 payment for Food and Beverage on 09/23/2024 Novartis Pharmaceuticals Corporation - $20.76 payment for Food and Beverage on 09/04/2024 Novartis Pharmaceuticals Corporation - $22.00 payment for Food and Beverage on 07/15/2024
|